Active Government Funding Opportunities

Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

Develop novel therapeutics and diagnostic tools to prevent, treat, or detect tick-borne diseases like Lyme disease. This program funds R&D to address a significant public health threat through innovative medical countermeasures.

This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

Develop and test broadly applicable clinical technologies addressing urgent military health needs through translational research and early-phase clinical trials. Multi-PI teams will advance platform products that benefit Service Members, Veterans, and their families.

DoD seeks clinical trial research to advance treatment and management of military-relevant diseases. This peer-reviewed program funds trials from early-phase (Phase 0/1) through large-scale Phase 3 studies, with optional planning support for regulatory preparation.

NSF seeks fundamental research advancing knowledge of STEM education across learning environments, broadening participation, and workforce development. Projects should generate foundational insights with potential long-term impact on educational practice across all learner groups and ages.

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

Support innovative research into rare melanoma subtypes to advance understanding of disease mechanisms and develop targeted treatment strategies. This Army-sponsored program funds basic and translational research addressing an underexplored cancer area with significant clinical impact.

DoD seeks innovative, high-risk autism research to accelerate discoveries and improve outcomes for autistic individuals. This award supports novel ideas with potential to generate impactful data and open new investigation pathways.

The Army seeks collaborative melanoma research teams to advance understanding and treatment of melanoma through innovative scientific approaches. This team science award supports competitive research that addresses critical gaps in melanoma biology and clinical outcomes.

Support clinical trials evaluating new treatments, devices, and approaches for autism management. Awards fund proof-of-concept through large-scale efficacy studies, with funding incentives for early-career researchers partnering with experienced mentors.

Support early-career researchers conducting innovative autism studies and proof-of-principle clinical trials. This award funds high-impact research ideas with required community partnership to advance autism understanding and treatment.

This Army Medical Research funding supports translational research addressing health impacts from toxic exposures on military personnel. Projects bridge discovery science to clinical solutions for affected service members and veterans.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.

This award funds translational research bridging discoveries in traumatic brain injury (TBI) and psychological health toward clinical applications. Research aims to advance understanding and treatment of TBI-related mental health conditions in military populations.

This Army funding opportunity supports investigator-initiated research into toxic exposures affecting military personnel, seeking novel scientific studies to understand health impacts and inform prevention strategies.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.

The Army seeks patient-centered research to advance burn treatment and recovery outcomes for military personnel. This funding supports innovative clinical studies and therapeutic approaches to improve care for burn-injured soldiers.

The Army seeks innovative research on military burn treatment and prevention through discovery-phase awards. This funding targets novel solutions to improve clinical outcomes for service members with severe thermal injuries.

The Army seeks melanoma research to advance understanding and treatment of this serious cancer. This Scholar Award supports innovative scientific studies that could improve patient outcomes and military medical capabilities.